Trevi Therapeutics, Inc. TRVI Unrealized gains (losses) on available-for-sale securities
Unrealized gains (losses) on available-for-sale securities at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s unrealized gains (losses) on available-for-sale securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s unrealized gains (losses) on available-for-sale securities?
- Trevi Therapeutics, Inc. (TRVI) reported unrealized gains (losses) on available-for-sale securities of -$338K in Q1 2026.
- How has Trevi Therapeutics, Inc.'s unrealized gains (losses) on available-for-sale securities changed year-over-year?
- Trevi Therapeutics, Inc.'s unrealized gains (losses) on available-for-sale securities decreased by 2916.7% year-over-year, from $12K to -$338K.
- What does unrealized gains (losses) on available-for-sale securities mean?
- Represents the change in the fair value of available-for-sale debt or equity securities that has not yet been realized through a sale. This metric captures market-driven fluctuations in the value of an entity's investment portfolio that are excluded from net income. It provides insight into the unrealized volatility of the company's liquid asset holdings.